chf

Mainstay Medical Announces Pre-IDE Submission for ReActiv8® to FDA

on 07/07/2014 11:26
Mainstay Medical continues progress towards the commercialisation of ReActiv8.
Read more

Trinean appoints Chris van Ingen as member of the board

on 02/05/2014 17:31
Trinean today announced that it appointed Mr Chris van Ingen as independent board member.
Read more

iSTAR Medical Adds Glaucoma Pioneer Prof. Michael Belkin, MD, to Scientific Advisory Board

on 29/04/2014 17:24
Prof. Belkin has been involved in the establishment of over 15 medical start-ups in ophthalmology and other fields.
Read more

Mainstay Medical to Euronext and Irish Stock Exchange

on 28/04/2014 17:35
Announcement of offer price and number of issued ordinary shares on admission to Euronext Paris and ESM.
Read more

Sequana Medical raises CHF 23 million

on 28/04/2014 11:50
Sequana Medical AG raises CHF 23 million in a Series C financing led by LSP, and adds an Independent Board Chairman and Vice President of Sales and Marketing.
Read more